A prospective interventional study investigating sleep disorders prior to and during adjuvant radiotherapy for breast cancer

Dirk Rades, Carlos A Narvaez, Liesa Dziggel, Stefan Janssen, Denise Olbrich, Soeren Tvilsted, Troels W Kjaer, Dirk Rades, Carlos A Narvaez, Liesa Dziggel, Stefan Janssen, Denise Olbrich, Soeren Tvilsted, Troels W Kjaer

Abstract

Background: Most breast cancer patients with non-metastatic disease receive adjuvant local or loco-regional radiotherapy. To be scheduled for irradiation may cause distress and fears that can lead to sleep disorders. Few reports focused on sleep problems in patients assigned to radiotherapy. This study evaluates the course of sleep disorders during adjuvant radiotherapy for primary breast cancer and potential risk factors including the use of smartphones or tablets at bedtime.

Methods: The main goal is the evaluation of sleep disorders prior to radiotherapy and after 15 fractions of radiotherapy. A potential effect of habituation to the procedure of radiotherapy can be assumed that will likely lead to improvement (decrease) of sleep disorders. Improvement of sleep disorders (compared to baseline before radiotherapy) is defined as decrease of the severity of sleep disorders by ≥2 points on a patient self-rating scale (0 = no problems; 10 = maximum problems) or decrease of distress caused by sleep disorders by ≥2 points on a self-rating scale (0 = no distress; 10 = maximum distress) or reduction of the dose of sleeping drugs by ≥25%. Additional endpoints include sleep disorders after 5 fractions and at the end of radiotherapy. Moreover, potential risk factors including the use of smartphones or tablets at bedtime are evaluated. Fifty-one patients (48 plus potential drop-outs) are required. With this sample size, a one-sample binomial test with a one-sided significance level of 2.5% has a power of 80% to yield statistical significance, if the rate of patients with improvement of sleep disorders is 25% (rate under the alternative hypothesis) and assuming that a decrease of ≤10% has to be judged as a random, non-causal change in this uncontrolled study setting (null hypothesis).

Discussion: If a decrease of sleep disorders during the course of radiotherapy is shown, this aspect should be included in the pre-radiotherapy consent discussion with the patients. Moreover, identification of additional risk factors will likely lead to earlier psychological support. If the use of smartphones or tablets at bedtime is a risk factor, patients should be advised to change this behavior.

Trial registration: clinicaltrials.gov (NCT04879264; URL: https://ichgcp.net/clinical-trials-registry/NCT04879264 ); registered on 7th of May, 2021.

Keywords: Adjuvant radiotherapy; Breast cancer; Prospective study; Sleep disorders; Smartphones.

Conflict of interest statement

Dirk Rades and Stefan Janssen are associate editors of BMC Cancer, Dirk Rades is member of the editorial board of BMC Neurology. No other competing interests exist regarding this study.

© 2021. The Author(s).

Figures

Fig. 1
Fig. 1
Timeline of enrolment, interventions and assessments of the RADIO-SLEEP study

References

    1. Siegel RL, Miller KD, Jemal A. Cancer statistics, 2021. CA Cancer J Clin. 2021;71:7–33. doi: 10.3322/caac.21654.
    1. German Guideline Program in Oncology. Adjuvant radiotherapy of breast cancer. In: Evidence-based Guideline Breast Cancer - Version 4.4. 2021;132–54.
    1. Savard J, Simard S, Blanchet J, Ivers H, Morin CM. Prevalence, clinical characteristics, and risk factors for insomnia in the context of breast cancer. Sleep. 2001;24:583–590. doi: 10.1093/sleep/24.5.583.
    1. Rades D, Narvaez CA, Dziggel L, Tvilsted S, Kjaer TW. Sleep disorders in patients with breast cancer prior to a course of radiotherapy – prevalence and risk factors. Anticancer Res. 2021;41:2489–2494. doi: 10.21873/anticanres.15026.
    1. Thomas KS, Bower J, Hoyt MA, Sepah S. Disrupted sleep in breast and prostate cancer patients undergoing radiation therapy: the role of coping processes. Psychooncology. 2010;19:767–776. doi: 10.1002/pon.1639.
    1. Savard J, Ivers H, Savard MH, Morin CM. Cancer treatments and their side effects are associated with aggravation of insomnia: results of a longitudinal study. Cancer. 2015;121:1703–1711. doi: 10.1002/cncr.29244.
    1. Chow E, Hoskin P, Mitera G, Zeng L, Lutz S, Roos D, Hahn C, van der Linden Y, Hartsell W, Kumar E. International bone metastases consensus working party: update of the international consenus on palliative radiotherapy endpoints for future clinical trials in bone metastases. Int J Radiat Oncol Biol Phys. 2012;82:1730–1737. doi: 10.1016/j.ijrobp.2011.02.008.
    1. Dhruva A, Paul SM, Cooper BA, Lee K, West C, Aouizerat BE, Dunn LB, Swift PS, Wara W, Miaskowski C. A longitudinal study of measures of objective and subjective sleep disturbance in patients with breast cancer before, during, and after radiation therapy. J Pain Symptom Manag. 2012;44:215–228. doi: 10.1016/j.jpainsymman.2011.08.010.
    1. US Department of Health and Human Services, National Institutes of Health, National Cancer Institute. Common Terminology Criteria for Adverse Events (CTCAE) Version 5.0. 2017.
    1. Rades D, Witteler J, Olbrich D, Trillenberg P, Schild SE, Tvilsted S, Kjaer TW. A prospective interventional study evaluating seizure activity during a radiotherapy course for high-grade gliomas (SURF-ROGG) BMC Cancer. 2021;21:386. doi: 10.1186/s12885-021-08121-y.
    1. Garrett K, Dhruva A, Koetters T, West C, Paul SM, Dunn LB, Aouizerat BE, Cooper BA, Dodd M, Lee K, Wara W, Swift P, Miaskowski C. Differences in sleep disturbance and fatigue between patients with breast and prostate cancer at the initiation of radiation therapy. J Pain Symptom Manag. 2011;42:239–250. doi: 10.1016/j.jpainsymman.2010.11.010.
    1. Palesh OG, Roscoe JA, Mustian KM, Roth T, Savard J, Ancoli-Israel S, Heckler C, Purnell JQ, Janelsins MC, Morrow GR. Prevalence, demographics, and psychological associations of sleep disruption in patients with cancer: University of Rochester Cancer Center-Community Clinical Oncology Program. J Clin Oncol. 2010;28:292–298. doi: 10.1200/JCO.2009.22.5011.
    1. Desai K, Mao JJ, Su I, Demichele A, Li Q, Xie SX, Gehrman PR. Prevalence and risk factors for insomnia among breast cancer patients on aromatase inhibitors. Support Care Cancer. 2013;21:43–51. doi: 10.1007/s00520-012-1490-z.
    1. Tag Eldin ES, Younis SG, Aziz LMAE, Eldin AT, Erfan ST. Evaluation of sleep pattern disorders in breast cancer patients receiving adjuvant treatment (chemotherapy and/or radiotherapy) using polysomnography. J BUON. 2019;24:529–534.
    1. Bartel K, Williamson P, van Maanen A, Cassoff J, Meijer AM, Oort F, Knäuper B, Gruber R, Gradisar M. Protective and risk factors associated with adolescent sleep: Findings from Australia, Canada, and the Netherlands. Sleep Med. 2016;26:97–103. doi: 10.1016/j.sleep.2016.07.007.
    1. Exelmans L, Van den Bulck J. Bedtime mobile phone use and sleep in adults. Soc Sci Med. 2016;148:93–101. doi: 10.1016/j.socscimed.2015.11.037.
    1. Polos PG, Bhat S, Gupta D, O'Malley RJ, DeBari VA, Upadhyay H, Chaudhry S, Nimma A, Pinto-Zipp G, Chokroverty S. The impact of sleep time-related information and communication technology (STRICT) on sleep patterns and daytime functioning in American adolescents. J Adolesc. 2015;44:232–244. doi: 10.1016/j.adolescence.2015.08.002.
    1. Lemola S, Perkinson-Gloor N, Brand S, Dewald-Kaufmann JF, Grob A. Adolescents' electronic media use at night, sleep disturbance, and depressive symptoms in the smartphone age. J Youth Adolesc. 2015;44:405–418. doi: 10.1007/s10964-014-0176-x.
    1. Exelmans L, Gradisar M, Van den Bulck J. Sleep latency versus shuteye latency: prevalence, predictors and relation to insomnia symptoms in a representative sample of adults. J Sleep Res. 2018;27:e12737. doi: 10.1111/jsr.12737.

Source: PubMed

Patrocinadores e Colaboradores

Condições médicas

Intervenções de drogas

3
Se inscrever